Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences

Audio By Carbonatix

IRVINE, Calif.--(BUSINESS WIRE)--Feb 19, 2026--

Edwards Lifesciences Corporation (NYSE: EW) today announced its chief financial officer, Scott Ullem, is scheduled to present at two upcoming conferences:

• Tuesday, March 10, 2026 at 10:00 a.m. ET at the Barclays 28th Annual Global Healthcare Conference
• Wednesday, March 11, 2026 at 10:00 a.m. ET at the Leerink Global Healthcare Conference

A live webcast of each presentation will be available on the Edwards investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260219060699/en/

CONTACT: Media Contact:Amy Meshulam,[email protected]

Investor Contact:[email protected]

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: HEALTH SURGERY CARDIOLOGY MEDICAL DEVICES

SOURCE: Edwards Lifesciences Corporation

Copyright Business Wire 2026.

PUB: 02/19/2026 07:05 AM/DISC: 02/19/2026 07:06 AM

http://www.businesswire.com/news/home/20260219060699/en